Gtaexs617

Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma

Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.Phase 1/2

—

Rating in progress

Gtaexs617 in Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active